 |
|
|
Health
2007 2006
2005 2004 2003
2002 2001
Documents
from 1995 to 2000 (click)
2007
Is
Product Patent Protection Necessary in Developing Countries for
Innovation? R&D by Indian Pharmaceutical Companies after TRIPS,
September 2007.
Author: Professor Sudip Chaudhuri, Indian Institute of Management,
Kolkata, India
Achieving
Both Access and Research: A Sector Agreement in Pharmaceuticals
John Barton
Expanding
the Public Healthcare Architecture to help meet MDG: Proposals for
the Long Term Funding and Management of a Pipeline of Essentail
Medicines through Development and Distribution
Author: Peter Brown
Patents
Without Monopolies
Author: Pablo Marion Challu
Fostering
R&D; and Promoting Access to Medicines
Author: Carlos Correa
Prize, Advanced Market Commitments, and Pharmaceuticals for Developing
Countries
Author: Aidan Hollis
Operationalising
Patent Pools for ARVs
Author: Warren Kaplan
The
Right to Health: What Corporate Duties?
Author: Klaus M. Leisinger
The
role of prizes in stimulating R&D;: Comment to WHO IGWG
Author: James Love
IGWG
Submission on Collective Management of Intellectual Property - The
Use of Patent Pools to Expand Access to Needed Medical Technologies
Author: Manon Ress
Putting Health on the Fast Track:
Compliance with the Doha Declaration on Public Health as a Principal
Negotiating Objective for Trade Promotion Authority, August
2007.
Author: Margaret Lee, CIEL
Intellectual Property Management in Health and Agricultural Innovation:
A Handbook of Best Practices, 2007.
MIHR and PIPRA
Facts and Evidences on The 10 Burning Issues Related to the
Government Use of Patents on Three Patented Essential Drugs in Thailand,
February 2007.
Document explaining the Thai decision to use compulsory licenses,
by the Ministry of Public Health and the National Health Security
Office, Thailand
Guidelines
for the examination of pharmaceutical patents: Developing a public
health perspective, January 2007.
Author: Carlos Correa
2006
Report on
Intellectual Property Rights, Innovation and Public Health,
2006.
CIPIH, WHO
The
Use of Flexibilities in TRIPS by Developing Countries: Can they
promote Access to Medicines?
Authors: Sisule. F. Musungu and Cecilia Oh
Protección
de productos farmacéuticos y agroquímicos ('productos
regulados') en DR-CAFTA
Carlos M. Correa
The
ability of select sub-Saharan African countries to utilise TRIPs
Flexibilities and Competition Law to ensure a sustainable supply
of essential medicines: A study of producing and importing countries.
Author: Tenu Avafia, Jonathan Berger and Trudi Hartzenberg
2005
Disembowelment
of India’s Patent Regime, 2005.
Dwijen Rangnekar, Centre for the Study of Globalisation
and Regionalisation, University of Warwick, UK
Intellectual
Property Quarterly Update, 2005.
Authors: South Centre and CIEL
Innovation
in Developing Countries to meet health needs, experiencs of South
Africa, Brazil, China and India
Country Reports for submission to the Commission on Intellectual
Property Rights, Innovation and Public Health
WHO
Commission on Intellectual Property Rights, Innovation and Public
Health, 21 studies, 2005.
Authors: various
Struggling to Balance Free Trade with Access to Medicines in the
post-TRIPS Era Throughout the Arab World, 2005.
Author: Othoman Mellouk, Association de Lutte Contre le Sida
(ALCS), Marrakech
Protecting Test Data for Pharmaceutical and Agrochemical Products
under Free Trade Agreements, 2005.
Author: Carlos M. Correa, University of Buenos Aires
Undisclosed Clinical Trial Data under the TRIPS Agreement and its
Progeny: A Broader Perspective, 2005.
Author: Jerome H. Reichman, Duke University School of Law
Intellectual Property and Pharmaceutical Data Exclusivity in the
Context of Innovation and Market Access, 2005.
Author: Meir Perez Pugatch, University of Haifa
Health and Intellectual Property Rights: Thoughts on Ensuring Access
to Medicines in 2005 and Beyond, 2005
Author: Karin Timmermans, World Health Organization Indonesia.
Intellectual property and pharmanceutical data exclusivity in the
context of innovation and market access, 2005.
Author: Mair Perez Pugatch, University of Haifa
Product development partnerships on 'neglect diseases': How they
handle intellectual property and how this may contribute to improving
access access to pharmaceuticals for HIV/AIDS, TB and Malaria,
2005.
Author: Roy Widdus, Global Forum for Research
Role, Perspectives and Challenges of the Generic Pharmaceutical
Industry in Latin America, 2005.
Author: Mirta Levis, Centro Industrial de Laboratorios Farmaceuticos
Argentinos
Creating And Promoting Domestic Drug Manufacturing Capacities: Legal
And Economic Feasibility Assessment, 2005.
Author: Juan Rovira, University of Barcelona, Spain and SOIKOS.
Market Concentration Of The Transnational Pharmaceutical Industry
And The Generic Industries In The World: Latest Trends on Mergers,
Acquisitions and Other Transactions, 2005.
Author: Barbara Rosenberg/ Ministry of Justice, Brazil.
2004
Dealmaking and Intellectual
Property Management for Public Interest, 2004.
Author: Cathy Garner / IPPPH / MIHR
Access
To Medicines And Drug Regulation In Developing Countries: A Resource
Guide For DFID, 2004.
Authors: Andy Gray / Department for International Development
Health Systems Resource Centre.
Access
to Medicines in Under-served Markets: What are the implications
of changes in intellectual property rights, trade and drug registration
policy?, 2004.
Author: Health Systems Resource Centre, the Department for
International Development.
Advancing
public health by other means: Using competition policy to increase
access to essential medicines, 2004.
Author: Jonathan Berger / UNCTAD-ICTSD.
Combating
Diseases Associated with Poverty: Financing Strategies for Product
Development and the Potential Role of Public-Private Partnerships,
2004.
Authors: Roy Widdus and Katherine White / The Initiative
on Public-Private Partnerships for Health (IPPPH).
Creating
And Promoting Domestic Drug Manufacturing Capacities: Legal And
Economic Feasibility Assessment, 2004.
Author: Juan Rovira / UNCTAD-ICTSD.
Finding
Cures for Tropical Diseases: Is Open Source an Answer? 2004,
Stephen M. Maurer, Arti Rai and Andrej Sali
The
FTA and the PBS - A submission to the Senate Select Committee on
the US-Australia Free Trade Agreement, May 2004.
Peter Drahos, Thomas Faunce, Martyn Goddard and David
Henry.
How Do Patents And Economic Policies Affect Access To Essential
Medicines In Developing Countries?, March/April 2004.
Amir Attaran, Health Affairs, Vol 23, Issue 3, 155-166.
Impact
of Public-Private Partnerships Addressing Access to Pharmaceuticals
in Selected Low and Middle Income Countries A Synthesis Report from
Studies in Botswana, Sri Lanka, Uganda and Zambia, 2004.
Authors: Karen Caines and Louisiana Lush / The Initiative
on Public-Private Partnerships for Health (IPPPH).
Implementation
of the Conevant on Civil and Political Rights in Uganda: Trade-related
intellectual property rights, access to HIV/AIDS medicines and the
fulfilment of civil and political rights, 2004.
3D.
La
Aplicacion de la Convencion sobre los Derechos del Nino en El Salvador:
La repercusión de los acuerdos comerciales internacionales
por los que se rigen los derechos de propiedad intelectual en el
acceso a los medicamentos y el respeto de los derechos del niño,
2004.
Author: 3D
Implementation
of the Convention on the Rights of the Child in El Salvador: The
impact of international trade agreements regulating intellectual
property rights on access to medicines and the fulfillment of children's
rights, 2004.
3D.
Implementation
of the WTO General Council Decision on Paragraph 6 of the Doha Declaration
on the TRIPS Agreement and Public Health, April 2004.
Carlos M. Correa, World Health Organization
Intellectual
Property and Pharmaceutical Data Exclusivity in the Context of Innovation
and Market Access, October 2004.
Author: Meir Perez Pugatch / UNCTAD-ICTSD.
La
Applicacion de la Convencion sobre los Derechos del Niño
en El Salvador: La repercusión de los acuerdos comerciales
internacionales por los que se rigen los derechos de propiedad intelectual
en el acceso a los medicamentos y el respeto de los derechos del
niño, 2004.
3D-THREE.
Market
Concentration Of The Transnational Pharmaceutical Industry And The
Generic Industries In The World: Latest Trends on Mergers, Acquisitions
and Other Transactions, 2004.
Author: Barbara Rosenberg / UNCTAD-ICTSD.
Ownership
of Knowledge: the Role of Patents in Pharmaceutical R&D,
October 2004.
Author: Carlos M. Correa, World Health Organization (WHO).
Patents,
Trade and Health: How Strong Patent Protection Affects Access to
Medicines Patents, Trade and Health, 2004.
Author: Jonathan Hepburn / Quaker International Affairs Programme,
Ottawa and Quaker United Nations Office, Geneva.
Processes
and Issues for Improving Access to Medicines: Willingness and Ability
to Utilise TRIPS Flexibilities in Non-Producing Countries, 2004.
Authors: Brook K. Baker / Health Systems Resource Centre,
the Department for International Development.
Product Development Partnerships on 'Neglected Diseases': How they
Handle Intellectual Property and how this may Contribute to Improving
Access to Pharmaceuticals for HIV/AIDS, TB and Malaria, October
2004.
Author: Roy Widdus / UNCTAD-ICTSD.
Protecting
Test Data for Pharmaceutical and Agrochemical Products under Free
Trade Agreements, 2004.
Author: Carlos M. Correa/ UNCTAD-ICTSD.
Public-Private
Management of Intellectual Property for Public Health Outcomes in
the Developing World The Lessons of Access Conditions in Research
and Development Agreements, 2004.
Authors: Antony Taubman / The Initiative on Public-Private
Partnerships for Health (IPPPH).
Public
Goods and the public domain: the access to konwledge in developing
countries, and innovation in health, education and science,
2004.
Author: Clemente Forero Pineda / UNCTAD-ICTSD.
Role,
Perspectives and Challenges of the Generic Pharmaceutical Industry
in Latin America, 2004.
Author: Mirta Levis / UNCTAD-ICTSD.
The
Cycle of Action and Reaction: Latest Developments and Trends in
IP and Health, October 2004.
Author: Frederick Abbott / UNCTAD-ICTSD.
The
Doha Declaration on the TRIPS Agreement and Public Health and the
Contradictory Trend in Bilateral and Regional Free Trade Agreements,
2004.
Author: Frederick Abbott / Quaker United Nations Office.
The
Effect of Changing Intellectual Property on Pharmaceutical Industry
Prospects in India and China:Considerations for Access to Medicines,
2004.
Authors: Cheri Grace / Health Systems Resource Centre, the
Department for International Development.
Utilizing
TRIPS Flexibilities for Public Health Protecton Through South-South
Regional Frameworks, 2004.
Authors: Sisule F. Musungu, Susan Villanueva, Roxana Blasetti
/ South Centre.
Health
and Intellectual Property Rights: Thoughts on Ensuring Access to
Medicines in 2005 and Beyond
Karin Timmermans, World Health Organization Indonesia.
2003
Accès
aux génériques et propriété intellectuelle,
2003.
Act Up Paris.
An
Agenda for Research and Development: Meeting on the Role of Generics
and Local Industry in Attaining the Millenium Development Goals
(MDGS) in Pharmaceuticals and Vaccines, 2003.
J. Love, T. Hubbard / Consumer Project on Technology
(CPTech) - Health Care and Intellectual Property (2003).
Application
of Methods related to Medical Activity to the Patent Law, 2003.
Patent System Subcommittee, Intellectual Property
Policy Committee, Industrial Structure Council, Japan.
Bioethical
Issues of IPRs. Theme 5: Practical Implications for Healthcare,
Access to Essential Medicines and Patents Holders, 2003.
Richard Ashcroft (Imperial College, London).
Can
'The Spirit of Doha' be Kept Alive?, 2003.
D. Dickson / SciDev.Net.
Derechos
de propiedad intelectual, innovación y salud pública,
2003.
Informe de la Secretaría, Organizacion Mundial
de la Salud.
Droits
de propriété intellectuelle, innovation et santé
publique, 2003.
Rapport du Secrétariat, Organisation Mondiale
de la Santé.
Droits
de propriété intellectuelle, innovation et santé
publique. Résolution de l'Assemblé Mondiale de la
Santé , 2003.
Cinquante-Sixième Assemblé Mondiale
de la Santé, 28 mai 2003.
From
TRIPS to RIPS: A better Trade Framework to support Innovation in
Medical Technologies, 2003.
James Love / Agence nationale de recherches sur le
sida/Institute d' économie publique, Workshop on Economic
issues related to access to HIV/AIDS care in developing countries,
27 May 2003.
FTAA:
Protectionism for US Drug Industry. Affordable AIDS Medicine Denied
in Latin America, 2003.
Health GAP (Global Access Project) / briefing document.
Implementing
the Doha Mandate on TRIPS and Public Health, 2003.
Fink C. / International Trade Department, World Bank.
Intellectual
Property Rights (IPRs) and Genetics: A Study into the Impact and
Management of Intellectual Property Rights within the Healthcare
Sector, 2003.
Authors: Professor W. R. Cornish, Dr M. Llewelyn, Dr M. Adcock.
Intellectual
Property Rights, Innovation and Public Health, 2003
Report by the Secretariat / World Health Organization,
12 May
Interpreting
Para 6, Deal on Patents and Access to Drugs, 2003.
K. Ravi Srinivas / The Economic and Political Weekly,
Mumbai.
L'accord
sur les droits de propriété intellectuelle et la santé
publique, 2003.
Raoul Marc Jennar / Démocratie et Socialisme,
4 septembre.
Medecine
Prices, A New Approach to Measurement, 2003.
Working draft for field testing and revision, World
Health Organization and Health Action International.
Open
Letter Concerning Intellectual Property and Access to Medicines
in The US-Central American Free Trade Agreement (CAFTA), 2003.
Médecins sans Frontières (MSF).
Out-licensing:
a practical approach for improvement of access to medicines in poor
countries, 2003.
Authors: Michael A Friedman, Henk den Besten, Amir Attaran
/ THE LANCET, Vol. 361.
Public Health Versus Intellectual Property, 2003.
Author: Servaas van Thiel
Tratado
Internacional de Propiedad Intelectual, 2003.
Carlos Correa / Observatorio de Salud, Medicamentos
y Sociedad, Argentina.
The
Impact of WTO Agreements on Health and Development Policies,
2003.
Meri Koivusalo / Globalism and Social Policy Programme.
TRIPS,
Drug Patents and Access to Medicines-Balancing Incentives for R&D
with Public Health Concerns, 2003.
Prof. Keith Maskus / Development Gateway Expert Perspective:
4 September 2003.
Simulation to the 5th
Ministerial Conference of the World Trade Organization on "
The TRIPS Agreement & its Implications on Public Health",
2003. Background document on this topic: The
World Trade Organization "The 5th Ministerial Conference", TRIPS
Agreement, Public Health a Challenging Battle.
Rami I. El-Dokany, Faculty of Economics & Political
Science, Cairo University, Egypt (the main paper contains the decisions
and recommendations adopted from this simulation by the Faculty).
Valuing
Industry Contributions to Public-Private Partnerships for Health
Product Development, 2003.
Authors: Hannah Kettler, Karen White and Scott Jordan /
Initiative on Public-Private Partnerships for Health.
Working
document on developing countries’ duties and taxes on essential
medicines used in the treatment of the major communicable diseases,
2003.
Directorate-General for Trade, European Commission.
2002
Access
to Essential Drugs may be Undermined by Global Patent Agreement,
2002.
Cooperation South Journal, United Nations
Development Programme, p.125-127.
Access
to Medicines and Public Policy Safeguards under TRIPS, 2002
Author: Dr. K. Balasubrarnaniam / Health Action International
Asia Pacific.
Access to
Medicines For All: A Major Human Rights Issue, 2002.
Narenda B. Zaveri / BRIDGES, ICTSD, Vol.
6, N°5, June 2002.
Access to Medicines:
Solving the Export Problem under TRIPS, 2002.
James Love / BRIDGES, ICTSD, Vol. 6, N°4,
May 2002.
Access
to Medicines: WTO Members May Snatch Defeat out the of Jaws of Victory,
2002.
Editorial / BRIDGES, ICTSD, Vol.6,
N°8, November-December 2002.
Amended
Patents Act and Access to Medicines after Doha, 2002.
P. Cullet / Economic and Political Weekly
XXXVII/24, 15 June 2002, p. 2278.
Anthrax,
Drug Transnationals, and TRIPS, 2002.
K. Singh / Foreign Policy in Focus (FPIF),
edited by John Gershman, 29 April 2002.
Arguments:
Access to Healthcare and IPRs — The Normative Issues, 2002.
Rainer Döbert / 8th Circular: Part Two: Access
to Health Care and IPRs — The Normative Issues, IPR Dialogue
Working Group III (Access to Essential Medicines).
Balancing
Health Needs and Drug Research Incentives, 2002.
Authors: Hannah H. Kettler, Chris Collins / Cooperation
South Journal - 2002, United Nations Development Programme,
p.10-36.
Beyond TRIPS: A New Global
Patent Regime, 2002.
Author: J. Olson Lanjouw / Center for Global Development
Brief, Vol.1, Issue N°3.
Bio-Pharmaceuticals
and Health, 2002.
Author: UNU/INTECH / Technology Policy Briefs, Vol.1,
Issue N°3.
Biopharmaceutiques
et santé - résumé, 2002.
Author: UNU/INTECH / Synthèse sur les Politiques
Technologiques, Vol. 1, N°3.
Compulsory
Licensing for Public Health Needs: The TRIPS Agenda at the WTO after
the Doha Declaration on Public Health, 2002.
F.M. Abbott / Occasional Paper 9, Quaker United
Nations Office (QUNO).
Historic
Doha Declaration on the TRIPS Agreement and Public Health, 2002.
Department of Essential Drugs and Medicines Policy,
WHO / Essential Drugs in Brief, Issue N°6, April 2002.
Impact
of Patents on Access to HIV/AIDS Drugs in Developing Countries,
2002.
Authors: J-R. Borrell, J. Watal / CID Working Paper, N°92.
Implications
of the Doha Declaration on the TRIPS Agreement and Public Health,
2002.
Authors: Carlos M. Correa / WHO Health Economics and Drugs,
EDM Series, N°12. CID Working Paper, N°92.
Intellectual
property and the availability of pharmaceuticals in poor countries,
2002.
J. Olson Lanjouw / Forthcoming in: Innovation
Policy and the Economy, National Bureau of Economic Research
(NBER), Vol. 3, 23 April 2002.
Intellectual
Property Rights in Biotechnology and Health Care — Results of a
Stakeholder Dialogue, 2002.
World Business Council for Sustainable Development
(ed.), Wissenschaftzentrum Berlin für Sozialforschung.
International
IP issues Post-Doha: Geographical Indications, Access to Medicines,
Biotechnology and other current issues, 2002.
Briefing chaired by Professor Andrew Christie, Intellectual
Property Research Institute of Australia, Speakers: David Hallett
and Peter Lawrence / Foreign Affairs and Trade, Office of Trade
Negociations, Australia.
Introducing
patent protection in the pharmaceutical sector : a first evaluation
for the Mexican case, 2002.
Authors: Emmanuel Combe, Pluvia Zuniga.
Issues
related to Access to Essential Medicines, 2002.
"Stakeholder Dialogue Process on the Issues
of Intellectual Property Rights in Biotechnology" organised
by WISSENSCHAFTSZENTRUM BERLIN FÜR SOZIALFORSCHUNG and World Business
Council for Sustainable Development.
L'accès
des pays pauvres aux médicaments, 2002.
Paul Benkimoun / Le Monde, 24.05.2002.
Le
commerce et la santé : priorité à l'accès
aux médicaments essentiels, 2002.
Authors: Gauri Sreenivasan et Ricardo Grinspun / Mondialisation
du commerce – Mondialisation de la pauvreté, Les enjeux
pour le Canada : perspectives des ONG, Conseil canadien pour
la coopération internationale, Série sur le commerce
et la pauvreté, Article 4.
Legal
Options for Implementing Paragraph 6 of the Ministerial Declaration
on the TRIPS Agreement and Public Health, 2002.
M.C.E.J Bronckers / Summary of Oral Presentation
at Quaker United Nations Office (QUNO) – Norway Ministry of Foreign
Affairs Meeting at Utstein Monastery, Norway, July 20-23, 2002
Legal
Options for Implementing Paragraph 6 of the Ministerial Declaration
on the TRIPS Agreement and Public Health, 2002.
Author: Frederick M. Abbott / Summary of Oral Presentation
at Quaker United Nations Office (QUNO) – Norway Ministry of
Foreign Affairs, Meeting at Utstein Monastery, Norway, July 20-23,
2002.
Medicina
tradicional, patentes y biopirater
a, 2002.
Silvia Ribeiro / La Jornada, México.
Patents
and Drug Prices, 2002.
Authors: World Business Council for Sustainable Development
and Wissenschaftzentrum Berlin für Sozialforschung.
Patents,
International Trade Law and Access to Essential Medicines, 2002.
Authors: Richard Elliot, Marie-Hélène Bonin
/ Canadian HIV/AIDS Legal Network & Médecins Sans Frontières
Canada.
Patents,
Pills and Public Health: Can TRIPS Deliver? 2002.
Author: Martin Foreman / The Panos Institute.
Pricing
Medicines to Benefit Poor Countries, 2002.
Author: Jagdish Bhagwati / Cooperation South Journal -
2002, United Nations Development Programme, p.37-39.
Promoting
Good Ideas on Drugs: Are Patents the Best Way? The Relative Efficiency
of Patent and Public Support for Bio-Medical Research, 2002.
Authors: Dean Baker and Noriko Chatani / Center for Economic
and Policy Research, Briefing Paper.
Proteccion
de los Datos Presentados para el Registro de Productos Farmacéuticos.
Implementacion de las Normas del Acuerdo TRIPS, 2002.
C. Correa / South Centre.
Protection
and Promotion of Traditional Medicine: Implications for Public Health
in Developing Countries, 2002.
C. Correa / South Centre.
Protection
of Data Submitted for the Registration of Pharmaceuticals: Implementing
the Standards of the TRIPS Agreement, 2002.
C. Correa / South Centre.
Reshaping
the TRIPS Agreement concerning Public Health: Two Critical Issues,
2002.
H. Sun.
Sobredosis
de ganancias, 2002.
Silvia Ribeiro / La Jornada, México.
Stakeholder
Dialogue Process on the Issues of Intellectual Property Rights in
Biotechnology: Issues related to Access to Essential Medicines and
to Access to Human Genetic Resources, 2002.
(Dialogue organised by the World Business Council
for Sustainable Development and Wissenschaftzentrum Berlin für
Socialforschung).
Summary
report on the Conference of the Commission on Intellectual Property
Rights, 2002.
International Institute for Sustainable Development
(IISD).
The
Doha Agenda and Intellectual Property Rights, 2002.
Phillip McCalman / prepared under the Asian Development
Bank’s (ADB) Regional Technical Assistance 5994: A Study on
Regional Integration and Trade: Emerging Policy Issues for Selected
Developing Member Countries.
The
FTAA, access to HIV/AIDS treatment, and human rights, 2002.
Human Rights Watch / A Human Rights Watch Briefing
Paper, 29 October 2002.
The
Role of Intellectual Property and Licensing in Promoting Research
in International Health: Perspectives from a Public Sector Biomedical
Research Agency, 2002.
Authors: Gerald T. Keusch, Rachel A. Nugent / CMH Working
Paper Series, Commission on Macroeconomics and Health, Paper
N°WG2 : 6.
The
WTO TRIPS Agreement and the Protection of Public Health: Implementing
paragraph 6 of the Doha Declaration, 2002.
Utstein Kloster / Report on the workshop organized
by the Quaker United Nations Office (QUNO) and the Ministry of Foreign
Affairs, Norway.
Trade
and Health: Focus on Access to Essential Medicines, 2002.
Authors: Gauri Sreenivasan, Ricardo Grinspun / Global
Trade/Global Poverty, NGO Perspectives on Key Challenges for Canada,
Canadian Council for International Co-operation, Trade and Poverty
Series, Paper N°4.
Trasnacionales
farmac uticas contra la salud, 2002.
Silvia Ribeiro / La Jornada, México.
TRIPS
and Non-violation Complaints: From a Public Health Perspective,
2002.
Author: Haochen Sun / Centre for WTO Studies.
TRIPS and
Pharmaceutical Industry: Issues and Prospects, 2002.
N. Lalitha.
TRIPS
and public health: the next battle, 2002.
Oxfam / Oxfam Briefing Paper, N°15.
TRIPS,
Intellectual Property Rights and Access to Medicines, 2002.
World Health Organization (WHO) / HIV/AIDS Antiretroviral
Newsletter, December 2002, Issue N°8.
Report
to the Prime Minister - UK Working Group on Increasing Access to
Essential Medicines in the Developing World: Policy Recommendations
and Strategies, 2002.
Clare Short / Departement for International Development
(DFID).
US
bullying on drug patents: one year after Doha, 2002.
Oxfam / Oxfam Briefing Paper, N°33.
Using
Innovative Action to Meet Global Health Needs through Existing Intellectual
Property Regimes, 2002.
Authors: Hannah E. Kettler, Chris Collins / Study Paper
2b, UK Commission on Intellectual Property Rights.
WTO
TRIPS Agreement and Its Implications for Access to Medicines in
Developing Countries, 2002.
F.M. Abbott / Study Paper 2a, UK Commission
on Intellectual Property Rights.
2001
Accessing
ARVs: untangling the web of price reductions for Developing Countries,
2001.
Authors: C. Perez-Casas, C. Macé, D. Berman, J. Double /
Access to Essential Medicines Campaign, MSF.
Access
to Medicines Could Become Doha’s (only?) Success Story, 2001.
Editorial / BRIDGES, ICTSD, Vol. 5, N°5,
June 2001.
Accord
sur les Aspects des Droits de Propriété Intellectuelle
liés au Commerce: l'Accès aux Médicaments entre
Intérêts Privés et Biens Publics, 2001.
Solagral / Réunion organisé par Solagral
dans le cadre du programme "Du citoyen à l'OMC".
A
Matter Of Life And Death: The Role Of Patents In Access To Essential
Medicines, 2001.
Médecins Sans Frontières (MSF).
A
patent policy proposal for global diseases, 2001.
J. Olson Lanjouw / Policy Brief, The Brookings
Institution, N°84.
A
Proposal to Use Patent Law to Lower Drug Prices in Developing Countries,
2001.
J. Olson Lanjouw / Commission on Macroeconomics
and Health CMH Working Paper Series Paper N°WG2: 11.
Are
patent rules compatible with access to essential medicines in developing
countries ?, 2001.
G. Dutfield / SciDev.Net.
Communication
from the European Communities and their Member States to the TRIPS
council: the relationship between provisions of the TRIPS Agreement
and access to medicines, 2001.
European Commission.
Construing
Intellectual Property Rights and Competition Policy Consistently
with Facilitating Access to Affordable AIDS Drugs to Low-End Consumers,
2001.
James Thuo Gathii / Florida Law Review, Vol
53, N°4.
Consumption
and trade in off-patented medicines, 2001.
H.E. Bale / Working Paper, Indian Council
for Research on International Economic Relations (ICRIER), N°65.
Dare
to lead: public health and company wealth, 2001.
Oxfam / Oxfam Briefing Paper on GlaxoSmithKline.
Differential
Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents,
2001.
Patricia M. Danzon / Commission on Macroeconomics
and Health CMH Working Paper Series, N°WG2 : 10.
Differentiated
pricing of patented products, 2001.
J.H. Barton / CMH Working Paper Series, Commission
on Macroeconomics and Health, Paper N°WG4 : 2.
Do
Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment
in Africa?, 2001.
Authors: L. Gillespie-White, A. Attaran / JAMA Special
Communication, American Medical Association, Vol. 286, N°15.
Draft
Declaration on the TRIPS Agreement and Public Health, 12.11.2001.
WTO.
Drug
companies vs. Brazil: the threat to public health, 2001.
Oxfam / Oxfam GB Briefing Paper.
Fatal
imbalance: the crisis in research and development for drugs for
neglected diseases, 2001.
Authors: the MSF Access to Essential Medicines Campaign and
the Drugs for Neglected Diseases Working Group.
Fatal
Side Effects: Medicine Patents under the Microscope, 2001.
Authors: M. Bailey, R. Mayne, Dr M. Smith / Oxfam GB.
Formula
for fairness: patient rights before patent rights, 2001.
Oxfam / Oxfam Company Briefing Paper on Pfizer,
N°1.
Generic
Drugs, Compulsory Licensing and Other Intellectual Property: Tools
for Improving Access to Medicine, 2001.
Author: M.A. Gollin / Occasional Paper 3, Quaker United
Nations Office (QUNO).
Generic
Exploring the Hidden Costs of Patents, 2001.
Author: S. Macdonald / Occasional Paper 4, Quaker
United Nations Office (QUNO).
Globalization,
patents and drugs: an annotated bibliography, 2001.
WHO Essential Drugs and Medicines Policy / Health
Economics and Drugs, EDM Series, N°10.
Globalization,
TRIPS and Access to Medicines, 2001
Dr Gro Harlem Brundtland, WHO / Statement on the
occasion of the 4th WTO Ministerial Conference, Doha, Qatar, 9 to
13 November 2001.
Globalization,
TRIPS and Access to Pharmaceuticals, 2001
WHO / WHO Policy Perspectives on Medicines.
Health
and intellectual property rights, 2001.
Carlos M. Correa / Editorial, Bulletin of the
World Health Organization (WHO), Vol. 79, N°5.
Implausible
denial: why the drug giants' arguments on patents don't stack up,
2001.
Oxfam / Oxfam Policy Papers, April 2001.
Intellectual
property and the knowledge gap, 2001.
Oxfam / Oxfam Discussion Paper, December 2001.
Intellectual
property rights in the global economy, 2001.
K. Maskus / Institute for International Economics.
Integrando
la Salud Publica en la Legislacion sobre Patentes de los Paises
en Desarrollo, 2001.
Carlos M. Correa / South Centre.
Intégration
des Considérations de Santé Publique dans la Législation en matière
de Brevets des Pays en Développement, 2001.
Carlos M. Correa / South Centre.
La
globalización, el Acuerdo sobre los ADPIC y el acceso a los productos
farmacéuticos, 2001.
OMS/ Perspectivas Politicas sobre Medicamentos
de la OMS.
Médicaments
: assouplissement des brevets, 2001.
Alpha Barry / Survivre au Sida.
Mondialisation,
ADPIC et accès aux produits pharmaceutiques, 2001.
OMS/ Perspectives Politiques de l'OMS sur les
Médicaments .
More
Equitable Pricing for Essential Drugs: What do we mean and what
are the issues?, 2001.
Background paper for the WHO-WTO secretariat workshop
on differential pricing and financing of essential drugs, Høsbjør,
Norway, 8-11 April.
Network
for Monitoring the Impact of Globalization and TRIPS on Access to
Medicines, 2001.
WHO Meeting Report, 19-21 February 2001, Chulalongkorn
University, Bangkok, Thailand.
Parallel
Imports of Pharmaceutical Products in the European Union, 2001.
Authors: M. Ganslandt, K. Maskus.
Parallel
Imports in Pharmaceuticals: Implications for Competition and Prices
in Developing Countries, 2001.
Keith E. Maskus / Final Report to World Intellectual
Property Organization under terms of Special Service Agreement.
Parallel
Trade - the case on Pharmaceuticals, 2001.
Ki-Huen Kwok / International Economic Relations.
Patent
Injustice: How World Trade Rules Threaten the Health of Poor People,
2001.
Oxfam / Oxfam’s Cut the Cost campaign.
Patent
Law, TRIPS, and R&D; Incentives: A Southern Perspective, 2001.
Carlos M. Correa / CMH Working Paper Series,
Commission on Macroeconomics and Health, Paper N°WG2: 12.
Patents
in Genomics and Basic Research: Issues for Global Health, 2001.
John Barton / CMH Working Paper Series, Commission
on Macroeconomics and Health, Paper N°WG2: 12.
Pills and
Pocketbooks: Equity Pricing of Essential Medicines in Developing
Countries, 2001.
E. Hoen 't / Médecins Sans Frontières (MSF), MSF
Campaign for Access to Essential Medicines.
Post-TRIPS
options for access to patented medicines in developing countries,
2001.
Authors: F.M. Scherer, J. Watal / CMH Working Paper Series,
Commission on Macroeconomics and Health, Paper N°WG41.
Priced out of Reach: How WTO patent policies will reduce access
to medicines in the developing world, 2001.
Oxfam / Oxfam Briefing Paper, N°4.
Protection of Traditional Medicine, 2001.
Richard Wilder / CMH Working Paper Series,
Commission on Macroeconomics and Health, Paper N°WG 4: 4.
Public-Private research for health, 2001.
Authors: V. Lehmann, G. Walt, L. Lush, B. Levings, P. Kahn,
R. Harbinson, N. Louwaars, M. Minderhoud, P. Mulvany, D. Rangnekar,
L. Pettiford, G. Frempong, E. Torreele / Biotechnology and Development
Monitor, N°46.
Report
of the workshop on differential pricing and financing of essential
drugs, 2001.
World Health Organization and World Trade Organization
Secretariats.
Responding
to market failures in tuberculosis control, 2001.
Authors: Rajesh Gupta, Jim Y. Kim, Marcos A. Espinal, Jean-Michel
Caudron, Bernard Pecoul, Paul E. Farmer, Mario C. Raviglione / Sciencexpress,
Policy Forum, 19 July 2001.
Santé
& Propriété Intellectuelle, 2001.
Gumisai Mutume / Afrique Relance, La lutte
contre le Sida en Afrique, Vol. 15, N°1.
Some
Assumptions on Patent Law and Pharmaceutical R&D;, 2001.
C. Correa / Occasional Paper 6, Quaker United
Nations Office (QUNO).
South
Africa vs. the Drug Giants A Challenge to Affordable Medicines,
2001.
Oxfam / Oxfam Background Briefing, February
01.
The
chemical industry comments on a possible new round & TRIPs,
2001.
European Chemical Industry Council.
The Declaration
on TRIPS and Public Health: A Step in the Right Direction, 2001.
Ellen't Hoen / BRIDGES, ICTSD, Vol. 5, N°9,
November-December 2001.
The
global AIDS crisis and the first 100 days of George W. Bush's Administration:
a report card from the health gap coalition, 2001.
Health GAP Coalition / Global Treatment Access Campaign
(GTAC).
The
Role of Intellectual Property and Licensing in Promoting Research
in International Health: Perspectives from a Public Sector Biomedical
Research Agency, 2001.
Authors: Gerald T. Keusch, Rachel A. Nugent / Commission
on Macroeconomics and Health (CMH) Working Paper Series, N°WG2
: 7.
The
TRIPS Agreement, Access to Medicines, and the Doha Ministerial Conference,
2001.
F.M. Abbott / Occasional Paper 7, Quaker United
Nations Office (QUNO).
TRIPS
and Health Emergencies, 2001.
United States Trade Representative / USTR Background
Paper, 10 November 2001.
TRIPS and
Public Health, Opportunities for Doha, 2001.
E. Herfkens / BRIDGES, ICTSD, Vol. 5, N°8,
October 2001.
TRIPS
and Public Health vs TRIPs and Pandemics?, 2001.
Editorial / BRIDGES, ICTSD, Vol. 5, N°8,
September 2001.
TRIPS
and R&D Incentives in the Pharmaceutical Sector, 2001.
Carlos M. Correa / CMH Working Paper Series,
Commission on Macroeconomics and Health, Paper N°WG2: 11.
TRIPS
and Rights: International Human Rights Law, Access to Medicines,
and the Interpretation of the WTO Agreement on Trade-Related Aspects
on Intellectual Property, 2001.
Richard Elliott / The Canadian HIV/AIDS Legal Network,
AIDS Law Project South Africa.
TRIPS
Disputes: Implications for the Pharmaceutical Sector , 2001.
C. Correa / Occasional Paper 5, Quaker United
Nations Office (QUNO).
What
did Doha accomplish?, 2001.
L. Gillespie-White / International Intellectual Property
Institute (IIPI).
WHO-WTO
Workshop on Differential Pricing and Financing of Essential Drugs,
8-11 April, 2001.
Jayashree Watal.
WHO-WTO
Workshop on Differential Pricing and Financing of Essential Drugs,
Executive Summary of Report, 8-11 April, 2001.
Author: World Health Organization (WHO) and World Trade Organization
Secretariats (WTO).
Workshop
on Differential Pricing and Financing of Essential Drugs: Session
V - Market Segmentation: techniques, actors and incentives - The
use of intellectual property rights, 2001. Executive
Summary of report
Richard Wilder / workshop organised by the World
Health Organization and World Trade Organization Secretariats
8-11 April 2001, Høsbjør, Norway.
WTO
patent rules and access to medicines: the pressure mounts, 2001.
Oxfam / Oxfam GB Background Briefing, June
2001.
|
|
|
|
|
